PODD Earnings & Financial Statements
Insulet Corporation
$138.76
+$4.83(+3.61%)
39
Overall
35
Value
27
Tech
57
Quality
Market Cap
$9.29B
Volume
473.68K
52W Range
$126.40 - $354.88
Target Price
$169.58
PODD earnings and financial statements: Insulet Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
PODD Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.71B | $2.07B | $1.70B | $1.31B | $1.10B |
| Cost of revenue | $768.20M | $625.90M | $537.20M | $499.70M | $346.70M |
| Operating income | $473.80M | $308.90M | $220.00M | $37.60M | $126.00M |
| EBITDA | $495.50M | $431.00M | $330.30M | $114.80M | $139.60M |
| Net income | $247.10M | $418.30M | $206.30M | $4.60M | $16.80M |
| EPS (diluted) | $3.48 | $5.78 | $2.94 | $0.07 | $0.24 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $3.19B | $3.09B | $2.59B | $2.25B | $2.05B |
| Total liabilities | $1.68B | $1.88B | $1.86B | $1.77B | $1.49B |
| Shareholders’ equity | $1.52B | $1.21B | $732.70M | $476.40M | $556.30M |
| Cash and equivalents | - | - | - | $674.70M | $791.60M |
| Long-term debt | $930.80M | $1.30B | $1.37B | $1.37B | $1.25B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $569.30M | $430.20M | $145.70M | $119.00M | -$68.10M |
| Capital expenditure | -$219.40M | -$134.00M | -$109.20M | -$157.30M | -$111.90M |
| Free cash flow | $349.90M | $296.20M | $36.50M | -$38.30M | -$180.00M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PODD | $138.76 | +3.6% | 473.68K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |